Online citations, reference lists, and bibliographies.
← Back to Search

Comparison Of Ultrasmall IONPs And Fe Salts Biocompatibility And Activity In Multi-cellular In Vitro Models

Natalia Janik-Olchawa, A. Drozdz, D. Ryszawy, Maciej Pudełek, Karolina Planeta, Z. Setkowicz, Maciej Śniegocki, A. Zadlo, B. Ostachowicz, J. Chwiej
Published 2020 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In the paper, the results of the first regular studies of ultra-small iron oxide nanoparticles (IONPs) toxicity in vitro were presented. The influence of PEG-coated NPs with 5 nm magnetite core on six different cell lines was examined. These were: human bronchial fibroblasts, human embryonic kidney cells (HEK293T), two glioblastoma multiforme (GBM) cell lines as well as GBM cells isolated from a brain tumor of patient. Additionally, mouse macrophages were included in the study. The influence of IONPs in three different doses (1, 5 and 25 µg Fe/ml) on the viability, proliferation and migration activity of cells was assessed. Moreover, quantifying the intracellular ROS production, we determined the level of oxidative stress in cells exposed to IONPs. In the paper, for the first time, the effect of Fe in the form of IONPs was compared with the analogical data obtained for iron salts solutions containing the same amount of Fe, on the similar oxidation state. Our results clearly showed that the influence of iron on the living cells strongly depends not only on the used cell line, dose and exposure time but also on the form in which this element was administered to the culture. Notably, nanoparticles can stimulate the proliferation of some cell lines, including glioblastoma multiforme. Compared to Fe salts, they have a stronger negative impact on the viability of the cells tested. Ultra-small NPs, also, more often positively affect cell motility which seem to differ them from the NPs with larger core diameters.
This paper references
10.1002/CHIN.201601215
In vivo Delivery, Pharmacokinetics, Biodistribution and Toxicity of Iron Oxide Nanoparticles
H. Arami (2016)
10.3978/j.issn.2223-4292.2011.08.03
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
Y. Wáng (2011)
10.18388/abp.2017_1592
Connexin-dependent intercellular stress signaling in tissue homeostasis and tumor development.
J. Czyż (2017)
focus on oxidative stress and apoptosis
J. Paunovic (2020)
10.2217/NNM-2016-0316
Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
L. Zhu (2017)
10.1007/BF02678498
The intravascular contrast agent Clariscan™ (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease
C. Klein (2007)
10.3390/ijms21093123
Removing Critical Gaps in Chemical Test Methods by Developing New Assays for the Identification of Thyroid Hormone System-Disrupting Chemicals—The ATHENA Project
A. Kortenkamp (2020)
10.1523/JNEUROSCI.3126-04.2004
Superparamagnetic Iron Oxide-Labeled Schwann Cells and Olfactory Ensheathing Cells Can Be Traced In Vivo by Magnetic Resonance Imaging and Retain Functional Properties after Transplantation into the CNS
M. Dunning (2004)
抗菌及び光触媒用の純粋及び銅(Cu)ドープZnOナノロッドの比較研究とそれらの作用機構
Bhuyan Tamanna (2015)
10.1002/jbt.22225
Toxicity of iron oxide nanoparticles: Size and coating effects
M. Abakumov (2018)
10.1007/s40089-017-0221-3
In vitro and in vivo toxicity assessment of nanoparticles
V. Kumar (2017)
10.1021/acsami.5b03873
Sulfhydryl-Modified Fe3O4@SiO2 Core/Shell Nanocomposite: Synthesis and Toxicity Assessment in Vitro.
Xueyi Guo (2015)
10.1016/J.BIOMATERIALS.2006.12.003
Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro.
K. Mueller (2007)
10.1016/j.addr.2008.03.018
Magnetic nanoparticles in MR imaging and drug delivery.
C. Sun (2008)
Feridex-FDA prescribing information, side effects and uses
Drugs
10.1021/acs.chemrestox.8b00110
Low Doses of Polyethylene Glycol Coated Iron Oxide Nanoparticles Cause Significant Elemental Changes within Main Organs.
A. Skoczeń (2018)
10.3390/nano7100307
Potential Toxicity and Underlying Mechanisms Associated with Pulmonary Exposure to Iron Oxide Nanoparticles: Conflicting Literature and Unclear Risk
Tiffany G. Kornberg (2017)
10.1016/J.BIOMATERIALS.2004.05.022
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
A. Gupta (2005)
10.1016/J.JMMM.2015.06.040
Synergistic effect of the combination of triethylene-glycol modified Fe3O4 nanoparticles and ultrasound wave on MCF-7 cells
Ali Ebrahimi Fard (2015)
conflicting literature and unclear risk
Kornberg (2017)
10.1016/j.tiv.2019.104676
High bisphenol A concentrations augment the invasiveness of tumor cells through Snail-1/Cx43/ERRγ-dependent epithelial-mesenchymal transition.
D. Ryszawy (2019)
10.1088/1752-7155/10/1/016004
Oxidative stress markers are elevated in exhaled breath condensate of workers exposed to nanoparticles during iron oxide pigment production.
D. Pelclova (2016)
10.1016/0730-725X(90)90143-P
A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent.
L. Josephson (1990)
10.1088/1361-6528/AB33D4
Synthesis of a superparamagnetic iron oxide based nano-complex for targeted cell death of glioblastoma cells.
Matthew Tovar (2019)
10.1111/j.1471-1842.2008.00811.x
Current status and future prospects.
K. A. McKibbon (2008)
Methods and challenges
Janita Raskala (2014)
Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells
B Ankamwar (2010)
size and coating effects
Abakumov (2018)
10.1038/nnano.2007.260
Intrinsic peroxidase-like activity of ferromagnetic nanoparticles.
Lizeng Gao (2007)
50 Years of Image Analysis
Geoff Jenkinson (2012)
10.1517/17425255.2012.637916
Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems
A. Sharma (2012)
oxidative damages on Hep G2 cells
L. Sadeghi (2015)
10.3389/fchem.2018.00360
Nanomedicine: Principles, Properties, and Regulatory Issues
S. Soares (2018)
10.7150/thno.25220
Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics
Wensheng Xie (2018)
Effect and intracellular uptake of pure magnetic Fe3O4 nanoparticles in the cells and organs of lung and liver.
Shi-yuan Liu (2009)
10.1155/2012/614094
Biocompatibility and toxicity of magnetic nanoparticles in regenerative medicine
H. Markides (2012)
10.1007/s11095-012-0900-8
Block Copolymer Cross-Linked Nanoassemblies Improve Particle Stability and Biocompatibility of Superparamagnetic Iron Oxide Nanoparticles
M. Dan (2012)
10.1038/nmeth.2089
NIH Image to ImageJ: 25 years of image analysis
C. Schneider (2012)
theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy
L. Zhu (2017)
10.3390/ijms161024417
In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles
U. Patil (2015)
10.1016/J.MSEC.2019.109810
Magnetic nanoparticles decorated with PEGylated curcumin as dual targeted drug delivery: Synthesis, toxicity and biocompatibility study.
M. Ayubi (2019)
10.3390/nano7010001
Improving Powder Magnetic Core Properties via Application of Thin, Insulating Silica-Nanosheet Layers on Iron Powder Particles
T. Ishizaki (2016)
10.1021/acsami.7b15116
Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.
Sebastian Pernal (2017)
10.2147/IJN.S17574
Evaluation of iron oxide nanoparticle biocompatibility
A. Hanini (2011)
10.1002/JAT.2550010103
Chronic studies in rats exposed to liquid effluent from coal gasification process
K. Kostial (1981)
10.1002/mrm.24216
Cell motility of neural stem cells is reduced after SPIO‐labeling, which is mitigated after exocytosis
Stacey M Cromer Berman (2013)
10.1088/0022-3727/36/13/203
TOPICAL REVIEW: Functionalisation of magnetic nanoparticles for applications in biomedicine
C. Berry (2003)
10.1021/cr900136g
Electro-Fenton process and related electrochemical technologies based on Fenton's reaction chemistry.
E. Brillas (2009)
10.1016/j.bbrep.2017.12.002
Comprehensive cytotoxicity studies of superparamagnetic iron oxide nanoparticles
R. Patil (2018)
synthesis, toxicity and biocompatibility study
Ayubi (2019)
10.1021/acsnano.9b01383
Elimination Pathways of Nanoparticles.
Wilson Poon (2019)
10.1007/s003300100908
Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging
Y. Wang (2014)
10.3109/08958378.2014.1001535
Exposure characteristics of ferric oxide nanoparticles released during activities for manufacturing ferric oxide nanomaterials
Mingluan Xing (2015)
10.1016/j.etp.2014.11.010
In vitro toxicity of iron oxide nanoparticle: oxidative damages on Hep G2 cells.
L. Sadeghi (2015)
10.1016/j.taap.2011.03.011
Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells.
A. Kunzmann (2011)
10.3390/ijms21030958
Therapeutic Efficiency of Multiple Applications of Magnetic Hyperthermia Technique in Glioblastoma Using Aminosilane Coated Iron Oxide Nanoparticles: In Vitro and In Vivo Study
Gabriel N A Rego (2020)
10.1007/s12013-012-9367-9
Oxidative Stress and Dermal Toxicity of Iron Oxide Nanoparticles In Vitro
A. Murray (2012)
10.1016/J.BIOMATERIALS.2003.12.046
Cell response to dextran-derivatised iron oxide nanoparticles post internalisation.
C. Berry (2004)
10.3748/wjg.v21.i47.13400
Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging.
Y. Wang (2015)
10.1007/s00216-010-3996-x
Toxicity assessment of nanomaterials: methods and challenges
A. Dhawan (2010)
10.1016/j.saa.2020.118355
FTIR microspectroscopy revealed biochemical changes in liver and kidneys as a result of exposure to low dose of iron oxide nanoparticles.
A. Drozdz (2020)
10.1088/0957-4484/21/7/075102
Biocompatibility of Fe(3)O(4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells.
B. Ankamwar (2010)
10.1021/acsnano.8b06201
Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumors.
Z. Shen (2018)
10.1039/c4nr05061d
Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice.
L. Yang (2015)
10.1007/s11051-015-3148-5
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages
A. Orlando (2015)
10.1002/jat.3953
Cytotoxicity, cellular uptake and apoptotic responses in human coronary artery endothelial cells exposed to ultrasmall superparamagnetic iron oxide nanoparticles
Teresa Palacios-Hernandez (2020)
10.1021/acs.molpharmaceut.6b00839
Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging.
Z. Shen (2017)
10.2147/IJN.S152461
Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)
M. Shevtsov (2018)
改善されたアップコンバージョン蛍光とMR緩和でのNaYF 4 :Yb, Er/NaGdF 4 ナノ結晶のシード媒介合成
Guo Hai (2010)
10.1021/cr2002596
Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2012)
10.1007/s12035-015-9259-2
Iron Oxide Nanoparticles Induce Dopaminergic Damage: In vitro Pathways and In Vivo Imaging Reveals Mechanism of Neuronal Damage
S. Imam (2015)
10.1039/c9tb02391g
Dual-targeting and excretable ultrasmall SPIONs for T1-weighted positive MR imaging of intracranial glioblastoma cells by targeting the lipoprotein receptor-related protein.
Chengjuan Du (2020)
10.2217/17435889.3.5.703
Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.
M. Longmire (2008)
principles, properties, and regulatory issues
S. Soares (2018)
10.1021/JP3101392
Physicochemical Origin for Free Radical Generation of Iron Oxide Nanoparticles in Biomicroenvironment: Catalytic Activities Mediated by Surface Chemical States
B. Wang (2013)
in vitro and in vivo study
Rego (2020)
current status of clinical application
Wang (2011)
considerations and caveats
M. Longmire (2008)
10.1080/10408444.2016.1181047
The effects of nanoparticles on the renal system
I. Iavicoli (2016)
10.1080/21691401.2019.1709855
Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues.
R. Vakili-Ghartavol (2020)
10.3402/nano.v1i0.5358
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)
N. Singh (2010)
10.3390/antibiotics7020046
Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity
L. S. Arias (2018)
10.2214/AJR.152.1.167
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
R. Weissleder (1989)
10.1016/j.taap.2008.09.030
Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line.
N. Monteiro-Riviere (2009)
10.1016/j.fitote.2019.02.020
Therapeutic potential of monoterpene α-thujone, the main compound of Thuja occidentalis L. essential oil, against malignant glioblastoma multiforme cells in vitro.
Maciej Pudełek (2019)
10.1007/s12011-007-0067-z
Effects of Nanoparticles on the Adhesion and Cell Viability on Astrocytes
Catherine Au (2007)
10.1016/j.cbi.2019.108935
Iron-based nanoparticles and their potential toxicity: Focus on oxidative stress and apoptosis.
J. Paunovic (2019)
In vitro sensitivity of pseudomonads from burned patients to colistin sulfate.
Graber Cd (1959)
10.2147/IJN.S13244
Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress
S. Naqvi (2010)
10.1166/JNN.2015.11704
Diosgenin Functionalized Iron Oxide Nanoparticles as Novel Nanomaterial Against Breast Cancer.
Sougata Ghosh (2015)
10.1039/C4TB00811A
Facile non-hydrothermal synthesis of oligosaccharides coated sub-5 nm magnetic iron oxide nanoparticles with dual MRI contrast enhancement effect.
Jing Huang (2014)
Magnetic nanoparticles in cancer
O. L. Gobbo (2015)
10.7150/thno.11544
Magnetic Nanoparticles in Cancer Theranostics
O. Gobbo (2015)
10.2217/nnm.10.106
Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects.
Stefaan J.H. Soenen (2010)
Superparamagnetic pharmacokinetics iron oxide and toxicity
R Weissleder (1989)
10.1371/journal.pone.0078435
Dose Dependent Side Effect of Superparamagnetic Iron Oxide Nanoparticle Labeling on Cell Motility in Two Fetal Stem Cell Populations
V. Diana (2013)
10.1016/j.jhazmat.2014.04.054
Review of iron-free Fenton-like systems for activating H2O2 in advanced oxidation processes.
A. D. Bokare (2014)



Semantic Scholar Logo Some data provided by SemanticScholar